AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Flerie AB

Net Asset Value Aug 4, 2025

6601_rns_2025-08-04_0833fc7a-ce92-4fba-8604-9687d9f114ba.pdf

Net Asset Value

Open in Viewer

Opens in native device viewer

NET ASSET VALUE – 31 July 2025

On the 31 July 2025 Flerie AB's Net Asset Value (NAV) was SEK 4,164 million and NAV per share was SEK 53.33.

Allocation of NAV Share of portfolio
company
Fair value
(MSEK)
Part of NAV per share
(SEK)
Share of
NAV
Product Development
Prokarium 42% 453 5.81 10.9%
Xspray Pharma 18% 343 4.39 8.2%
Empros Pharma 79% 204 2.62 4.9%
Atrogi 44% 197 2.52 4.7%
KAHR Medical 30% 184 2.36 4.4%
Lipum 57% 171 2.19 4.1%
Xintela 59% 158 2.02 3.8%
Microbiotica 10% 129 1.65 3.1%
Mendus 23% 107 1.37 2.6%
Geneos Therapeutics 12% 94 1.20 2.2%
AnaCardio 13% 79 1.02 1.9%
Synerkine Pharma 44% 59 0.76 1.4%
EpiEndo Pharmaceuticals 9% 55 0.71 1.3%
Vitara Biomedical 11% 49 0.62 1.2%
Buzzard Pharmaceuticals 14% 32 0.40 0.8%
Egetis Therapeutics 1% 31 0.39 0.7%
Sixera Pharma 24% 27 0.35 0.7%
Toleranzia 14% 18 0.22 0.4%
Amarna Therapeutics 58% 11 0.14 0.3%
Strike Pharma 18% 11 0.13 0.3%
Alder Therapeutics 30% 8 0.10 0.2%
Total 2,418 30.98 58.1%
Commercial Growth
NorthX Biologics 61% 202 2.59 4.8%
Symcel 30% 192 2.46 4.6%
Nanologica 44% 74 0.95 1.8%
Chromafora 30% 73 0.93 1.7%
Frontier Biosolutions 2% 18 0.24 0.4%
Bohus Biotech 45% 17 0.21 0.4%
Total 576 7.38 13.8%
Limited Partnerships, total 107 1.37 2.6%
Assets related to Portfolio
companies
293 3.75 7.0%
Other assets and liabilities 769 9.85 18.5%
Net Asset Value 4,164 53.33 100.0

For more information:

Ted Fjällman, CEO Email: [email protected]

Flerie in brief

Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie's active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB's ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com

Attachments

NET ASSET VALUE – 31 July 2025

Talk to a Data Expert

Have a question? We'll get back to you promptly.